Notably, breast cancer seldom exhibits mutations in IDH1 and IDH2, which are known to drive 2HG accumulation in gliomas and leukemia [46], suggesting alternative mechanisms are responsible for the elevated 2HG levels observed in breast cancer. This evidence concerns the gene IDH2 and breast carcinoma.